SCHEMBL7334611

SCHEMBL7334611

CC(C)(C)OC(=O)N1C(=O)C[C@H](O)[C@H]1Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KLK7 P49862 8/20 0.51
▸ KLK5 Q9Y337 7/20 0.47
▸ PRSS1 P07477 3/20 0.46
▸ PRSS2 P07478 3/20 0.46
▸ PRSS3 P35030 3/20 0.46
▸ RIPK1 Q13546 2/20 0.43
▸ JAK2 O60674 1/20 0.41
▸ JAK1 P23458 1/20 0.41
▸ PLA2G10 O15496 1/20 0.41
▸ PLA2G5 P39877 1/20 0.41
▸ STS P08842 1/20 0.41
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA7 P43166 1/20 0.40
▸ CA14 Q9ULX7 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ NR1H2 P55055 2/20 0.39
▸ NR1H3 Q13133 2/20 0.39
▸ ABCB1 P08183 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10387738 1.00 KLK7 (0.51) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL10386719 1.00 KLK7 (0.51) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL247530 0.83 KLK7 (0.54) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL7331869 0.81 ALDH1A1 (0.43) KLK7RIPK1KMT2A
SCHEMBL3730644 0.81 NR1H2 (0.45) KLK7RIPK1KMT2ANR1H2
SCHEMBL823090 0.79 POLB (0.55) RIPK1KMT2A
SCHEMBL817748 0.79 POLB (0.55) RIPK1KMT2A
SCHEMBL29246175 0.78 SMYD2 (0.38) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL30188688 0.78 SMYD2 (0.38) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL29246174 0.78 SMYD2 (0.38) KLK7KLK5PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 — — EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 — — US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 — — US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 — — US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 — — US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 — — US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 — — US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 — — US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 — — EP disclosed
Send feedback